Welcome to LookChem.com Sign In|Join Free

CAS

  • or

211555-05-4

Post Buying Request

211555-05-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

211555-05-4 Usage

General Description

JAK3 Inhibitor I is a chemical compound designed to specifically target and inhibit the Janus kinase 3 (JAK3) enzyme, which plays a crucial role in the immune system and is involved in the development and functioning of certain types of immune cells. By inhibiting this enzyme, JAK3 Inhibitor I has the potential to modulate immune responses and has been investigated as a potential therapeutic agent for autoimmune disorders and inflammatory diseases. Research on this compound has shown promising results in preclinical studies, and it could be a valuable tool for studying the role of JAK3 in immune system function and developing new treatments for immune-related conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 211555-05-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,1,5,5 and 5 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 211555-05:
(8*2)+(7*1)+(6*1)+(5*5)+(4*5)+(3*5)+(2*0)+(1*5)=94
94 % 10 = 4
So 211555-05-4 is a valid CAS Registry Number.

211555-05-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,6-dibromo-4-[(6,7-dimethoxyquinazolin-4-yl)amino]phenol

1.2 Other means of identification

Product number -
Other names WHI-P97

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:211555-05-4 SDS

211555-05-4Upstream product

211555-05-4Downstream Products

211555-05-4Relevant articles and documents

Quinazoline formulations and therapeutic use thereof

-

, (2008/06/13)

Pharmaceutical compositions for parenteral administration of poorly soluble quinazoline compounds in the form of microemulsions or micellar solutions are described. The compositions are useful in treating patients suffering from cancer or having allergic

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 211555-05-4